Pharmacologic treatment of dimensional anxious depression: a review - Wikidata - awgldk - TriplyDB

Pharmacologic treatment of dimensional anxious depression: a review

Pharmacologic treatment of dimensional anxious depression: a review

http://www.wikidata.org/entity/Q34331887

about

Pharmacological approaches to the challenge of treatment-resistant depression A Randomized Controlled Trial of Mindfulness-Based Cognitive Therapy for Treatment-Resistant Depression.Experimental medication treatment approaches for depression.Psychiatric Comorbidity in Alcohol Dependence Adjunctive brexpiprazole in patients with major depressive disorder and anxiety symptoms: an exploratory study A randomized, placebo-controlled pilot trial of the delta opioid receptor agonist AZD2327 in anxious depression.Recognition of emotional facial expressions in anxious and nonanxious depression.Ziprasidone augmentation for anxious depression.The role of anxious distress in immune dysregulation in patients with major depressive disorder.

P2860

Q26798241-75F5A68A-7E1D-431E-96CC-489ED87CC251 Q30383857-CA8DA418-22AA-4D37-B2CB-CD4CF34FD142 Q33635577-DEB7B1F7-6069-4C49-8465-13439F4944B8 Q37252602-8C4FEA33-2C26-457F-9860-D579CED669AC Q37339751-334E8E6C-2CA8-41DD-8368-966AFAD659D3 Q37405727-7210E9A1-C5F2-4A5D-B586-92BEFAC4183E Q41638492-5AF0A895-64B0-4345-81E5-06DBAE4741E5 Q42593330-39E4B4DC-9F6B-48F3-8C34-44BC5A8DF37F Q47317496-B1EAE6C1-EFB0-4E34-8CEE-5B9029BA2BA7

P2860

Pharmacologic treatment of dimensional anxious depression: a review

http://www.wikidata.org/entity/Q34331887

description

2014 nî lūn-bûn

@nan

2014 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

name

Pharmacologic treatment of dimensional anxious depression: a review

@ast

Pharmacologic treatment of dimensional anxious depression: a review

@en

Pharmacologic treatment of dimensional anxious depression: a review

@nl

type

label

Pharmacologic treatment of dimensional anxious depression: a review

@ast

Pharmacologic treatment of dimensional anxious depression: a review

@en

Pharmacologic treatment of dimensional anxious depression: a review

@nl

prefLabel

Pharmacologic treatment of dimensional anxious depression: a review

@ast

Pharmacologic treatment of dimensional anxious depression: a review

@en

Pharmacologic treatment of dimensional anxious depression: a review

@nl

P1433

Q34331887-A9151C71-3C82-4E6F-956B-93D89B5279C4

P1476

Q34331887-8DC1B5EB-DFDD-4CCB-AD6C-1A7015BFE021

P2093

Q34331887-027EFC84-8CAE-4B52-878D-43ED9144743B

Q34331887-34021B87-71CB-44B7-A0CA-75909A78DCD6

Q34331887-63D19F70-2B83-440C-90DC-F81EA7F0A91D

P2860

Q34331887-05D0839F-9425-4F4D-952B-5723C1E46E74

Q34331887-0E31698D-6C37-4268-A359-77412890F4F9

Q34331887-1308A61B-4AAB-4588-BCDA-29EE550ABBFB

Q34331887-211F0E25-B689-4E23-B063-BA2B4D593FFE

Q34331887-247C8F57-377A-4DD1-9DDD-C3387E7FBBDD

Q34331887-3C83C377-9F0C-428E-B4F1-DF15FDE7CA8A

Q34331887-3E4A7239-FF04-45A2-917F-A1BDCA4AAFC8

Q34331887-41DD34BC-644E-4F48-B33D-855B0D40DE2F

Q34331887-41DE37E7-4119-465A-A48C-82D3DA9C30D3

Q34331887-41F9C35A-DCCE-410B-80B3-BAAB014CB9E8

P31

Q34331887-3103A1E3-3906-4E31-8329-C654C19E24FE

P356

Q34331887-4914B3C9-7585-4BE3-A990-510C72FAB14B

P433

Q34331887-3B3D13DD-5FA3-4F69-8546-E58DF94DC327

P478

Q34331887-8C2FD7B1-3D50-4313-8210-EB901201B21F

P50

Q34331887-36BB7125-385B-46C3-BBC2-13E19299D8CF

P577

Q34331887-0B49E0F7-9FF2-449F-95E9-03090817502A

P698

Q34331887-112D9A19-9AEB-430B-99B6-200D0D852E41

P932

Q34331887-E83D9000-3282-40C0-93C7-CB156DFE5DA8

P356

P1433

The primary care companion for CNS disorders

P1476

Pharmacologic treatment of dimensional anxious depression: a review

@en

P2093

Carlos A Zarate

http://www.w3.org/2001/XMLSchema#string

Dawn F Ionescu

http://www.w3.org/2001/XMLSchema#string

Erica M Richards

http://www.w3.org/2001/XMLSchema#string

P2860

Antidepressant effects of the muscarinic cholinergic receptor antagonist scopolamine: a review

Developing biomarkers in mood disorders research through the use of rapid-acting antidepressants

Therapeutic efficacy of antidepressants in agitated anxious depression--a meta-analysis of moclobemide studies

Neurobiology of anxious depression: a review

Anxiety does not predict response to duloxetine in major depression: results of a pooled analysis of individual patient data from 11 placebo-controlled trials.

Anxious depression and early changes in the HAMD-17 anxiety-somatization factor items and antidepressant treatment outcome

Randomized trial of sertraline versus venlafaxine XR in major depression: efficacy and discontinuation symptoms.

Efficacy of bupropion and the selective serotonin reuptake inhibitors in the treatment of major depressive disorder with high levels of anxiety (anxious depression): a pooled analysis of 10 studies.

Ketamine for depression: where do we go from here?

Comorbid anxiety and depression.

P31

scholarly article

P356

10.4088/PCC.13R01621

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-05-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25317369

http://www.w3.org/2001/XMLSchema#string

P932

4195641

http://www.w3.org/2001/XMLSchema#string